Lakefront Biotherapeutics | GLPG - Loan Capital

Stock Price
22.66
Daily Change
-0.74 -3.16%
Monthly
-8.85%
Yearly
-8.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR4.85M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 25.96B 177M Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Incyte USD 29.41M 785K Mar/2026
Merck EUR 10.73B 277M Dec/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 37.45B 7.86B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025